Serial Number | 98674072 |
Word Mark | OSMOTICA |
Filing Date | Tuesday, July 30, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Wednesday, February 19, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Custom manufacture of pharmaceutical preparations; Manufacturing services for others in the field of pharmaceutical products |
Goods and Services | Pharmaceutical products development; Development of pharmaceutical preparations and medicines; Pharmaceutical research and development; Pharmaceutical company services, namely, professional medical company services being pharmaceutical product research and development; Pharmaceutical research and development |
International Class | 040 - Treatment of materials. |
US Class Codes | 100, 103, 106 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, July 30, 2024 |
Primary Code | 040 |
First Use Anywhere Date | Friday, June 30, 2000 |
First Use In Commerce Date | Friday, June 30, 2000 |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, July 30, 2024 |
Primary Code | 042 |
First Use Anywhere Date | Friday, June 30, 2000 |
First Use In Commerce Date | Friday, June 30, 2000 |
Party Name | Osmotica Pharmaceutical US LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Alpharetta, GA 30005 |
Event Date | Event Description |
Tuesday, July 30, 2024 | NEW APPLICATION ENTERED |
Thursday, January 16, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, February 19, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, February 19, 2025 | NON-FINAL ACTION E-MAILED |
Wednesday, February 19, 2025 | NON-FINAL ACTION WRITTEN |
Thursday, February 6, 2025 | ASSIGNED TO EXAMINER |